Literature DB >> 14622235

Facilitation of conditioned taste aversion learning by systemic amphetamine: role of nucleus accumbens shell dopamine D1 receptors.

Sandro Fenu1, Gaetano Di Chiara.   

Abstract

The role of dopamine (DA) in associative learning was studied in a conditioned taste aversion (CTA) paradigm with sucrose as the conditioned stimulus (CS) and intraperitoneal lithium chloride as the unconditioned stimulus (US). Drinking on trial of a 15% sucrose solution followed 1 h later by lithium chloride (20 or 40 mg/kg i.p.) resulted in mild CTA, as shown by reduction of drinking of the sucrose solution 24 h later. Amphetamine sulphate (0.125, 0.25, 0.50 and 1.0 mg/kg s.c.), administered on trial 5 min after sucrose drinking, facilitated CTA with maximal effects at 0.25 mg/kg s.c. Amphetamine given in the absence of lithium or 45 min after sucrose did not affect sucrose intake. The DA D1 receptor antagonist SCH 39166, administered before amphetamine either systemically (0.0125 mg/kg s.c.) or in the nucleus accumbens shell (NAc; 0.025 micro g/ micro L on each side) prevented the facilitation of CTA induced by amphetamine. It is concluded that amphetamine facilitates CTA learning by strengthening the consolidation of gustatory short-term memory via D1 receptors of the NAc shell.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14622235     DOI: 10.1046/j.1460-9568.2003.02899.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  13 in total

1.  Appetitive sensitization by amphetamine does not reduce its ability to produce conditioned taste aversion to saccharin.

Authors:  John Scott-Railton; Gretchen Arnold; Paul Vezina
Journal:  Behav Brain Res       Date:  2006-10-04       Impact factor: 3.332

2.  Post-training, but not post-reactivation, administration of amphetamine and anisomycin modulates Pavlovian conditioned approach.

Authors:  Cory A Blaiss; Patricia H Janak
Journal:  Neurobiol Learn Mem       Date:  2007-01-26       Impact factor: 2.877

3.  Computational models of reinforcement learning: the role of dopamine as a reward signal.

Authors:  R D Samson; M J Frank; Jean-Marc Fellous
Journal:  Cogn Neurodyn       Date:  2010-03-21       Impact factor: 5.082

4.  D1 and D2 antagonists reverse the effects of appetite suppressants on weight loss, food intake, locomotion, and rebalance spiking inhibition in the rat NAc shell.

Authors:  B Kalyanasundar; Claudia I Perez; Alvaro Luna; Jessica Solorio; Mario G Moreno; David Elias; Sidney A Simon; Ranier Gutierrez
Journal:  J Neurophysiol       Date:  2015-05-13       Impact factor: 2.714

5.  Persistent expression of methamphetamine-induced CTA in periadolescent rats.

Authors:  Steven B Harrod; Ryan T Lacy; Lauren E Ballina
Journal:  Pharmacol Biochem Behav       Date:  2010-07-23       Impact factor: 3.533

6.  Post-training and post-reactivation administration of amphetamine enhances morphine conditioned place preference.

Authors:  Cory A Blaiss; Patricia H Janak
Journal:  Behav Brain Res       Date:  2006-05-15       Impact factor: 3.332

Review 7.  The debate over dopamine's role in reward: the case for incentive salience.

Authors:  Kent C Berridge
Journal:  Psychopharmacology (Berl)       Date:  2006-10-27       Impact factor: 4.530

8.  Differential involvement of dopamine receptors in conditioned suppression induced by cocaine.

Authors:  Ivana Grakalic; Leigh V Panlilio; Eric B Thorndike; Charles W Schindler
Journal:  Eur J Pharmacol       Date:  2007-06-30       Impact factor: 4.432

9.  Chronic D-amphetamine administered from childhood to adulthood dose-dependently increases the survival of new neurons in the hippocampus of male C57BL/6J mice.

Authors:  E C Dabe; P Majdak; T K Bhattacharya; D S Miller; J S Rhodes
Journal:  Neuroscience       Date:  2012-11-20       Impact factor: 3.590

10.  The effects of yohimbine and amphetamine on fear expression and extinction in rats.

Authors:  Devin Mueller; Lening A Olivera-Figueroa; Daniel S Pine; Gregory J Quirk
Journal:  Psychopharmacology (Berl)       Date:  2009-02-26       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.